Research, policy, and breakthroughs in women's health.
A new surge in menopause awareness swept the cultural mainstream this week as Gen X punk icons rallied at Menopunkapalooza, while researchers project infertility cases will surge to 80 million globally by 2036, driven primarily by delayed motherhood among women over 35. Congressional efforts to protect reproductive access continue advancing.
A groundbreaking immunotherapy study offers hope for women with premature ovarian insufficiency, with 30% of participants achieving pregnancy. Meanwhile, regulatory updates loom for menopause management and contraceptive options, while employers expand women's health benefits nationwide.
Fresh research reveals hormone replacement therapy's unexpected bone health benefits for menopausal women, while a new toolkit addresses menopause care disparities in minority ethnic communities. The global women's health market continues rapid expansion, reaching $44.1 billion in 2025 with projected growth to $60.4 billion by 2034.
A landmark publication in The Lancet has officially recognized the broader metabolic impacts of PCOS by renaming it PMOS (Polyendocrine Metabolic Ovarian Syndrome). Meanwhile, Apple has expanded its Health app to track menopause and perimenopause symptoms, and new research from the University of Vermont highlights critical brain changes during menopause—reinforcing that this transition is a neurological milestone, not just a reproductive one.
New research links infertility to earlier menopause onset, while Melinda French Gates commits $215 million to women's reproductive and midlife health. Meanwhile, menopause research funding gaps persist despite affecting millions annually.
New research reveals estrogen loss during menopause triggers brain changes linked to memory decline, while a Mayo Clinic study finds hormone therapy use remains low despite proven benefits. Major women's health conferences and femtech innovation accelerate as investment in midlife health reaches critical mass.
This week brings critical updates on women's reproductive health misinformation, cognitive benefits of longer reproductive lifespans, and emerging menopause research. Healthcare leaders are addressing online myths about perimenopause and contraception, while new studies reveal how reproductive history impacts brain health in aging women.
This week brings a surge of breakthrough research on menopause, cognition, and cardiovascular health. A landmark study from Northwestern Medicine pinpoints estrogen loss in brain tissue as a driver of post-menopausal memory decline, while new data from the Nurses' Health Study links longer reproductive lifespans to better cognitive performance in older women. Meanwhile, Iowa State University launches a new study tracking how distinct menopause stages reshape brain health — and doctors and experts are pushing back against a wave of online perimenopause misinformation.
This week's top developments in women's health span a landmark market forecast for menopause therapies, a new award-winning probiotic designed specifically to support the pregnancy microbiome, and growing momentum around heart health gaps exposed at a major industry summit. Research and innovation are converging to address long-underserved life stages — from pregnancy to midlife and beyond.
A landmark study reveals that Polyendocrine Ovarian Syndrome (formerly PCOS) continues to affect women well beyond menopause, calling for lifelong care. Meanwhile, a new World Economic Forum radar—developed with the Gates Foundation—exposes a stark funding gap: women's health receives only 20% of R&D investment globally, with fewer than 3% of clinical trials being women-specific. Harvard's first Women's Health Student Summit and new American Academy of Sleep Medicine data on menopausal sleep disruption round out a week of urgent findings.
New American Heart Association data confirms that heart health measurably declines as women enter perimenopause, underscoring the transition as a critical window for cardiovascular intervention. On the investment front, Wellcome Leap and Pivotal have pledged $100 million to women's health research, bringing Leap's cumulative women's health investment to $250 million. Meanwhile, a new bicameral bill introduced this week aims to improve reproductive healthcare access for women with disabilities.
A major Cleveland Clinic report reveals a significant knowledge gap among women regarding their elevated Alzheimer's risk, while new research highlights breakthroughs for women over 50 including a landmark type 1 diabetes trial. Workplace menopause policy adoption remains critically low, with only 18% of women reporting their employer has one in place.
This week's top story is Oura's new platform update introducing a Menopause Impact Scale and deeper hormonal birth control tracking, marking a significant step in consumer femtech. A landmark study published in *New Scientist* finds that PCOS delays perimenopause onset in most patients, potentially extending fertility windows. Meanwhile, Mother's Day spotlights persistent equity gaps in women's health research, with advocates and academics calling for stronger investment in midlife and menopause science.
New research confirms that menopause-related symptoms are strongly correlated with sleep disruption, while a Georgia Tech study finds menopause remains the most under-researched life stage compared to other reproductive health topics. Meanwhile, Oura's smartring platform expands its women's health tracking capabilities with new birth control and menopause features, and a landmark Nature Aging study maps how female reproductive organs age at different rates.
This week's top developments in women's health span a major market projection placing the women's healthcare sector on a trajectory toward $600 billion by 2030, a significant policy debate over the UK's renewed Women's Health Strategy, and fresh nonhormonal therapy options reshaping menopause care. Meanwhile, new environmental research links air pollution and poor groundwater quality to disrupted reproductive timelines in women.
Virginia Tech scientists have published a landmark study offering a new explanation for why cardiovascular disease risk rises after menopause — pointing to gene activity changes, not just hormone decline. Meanwhile, a new study in *Communications Medicine* links air pollution and groundwater quality to altered menopause and menarche timing in India, and the women's health industry continues to rethink the language around perimenopause care.
This week's top findings span three major fronts in women's health: a landmark study confirms that longer natural reproductive years are linked to slower cognitive decline; new research from Nature Medicine reveals how air pollution and poor water quality affect the timing of menstruation and menopause in India; and the launch of WINCEE signals a growing institutional push to close gender gaps in clinical research. Meanwhile, a Medscape clinical update challenges providers to take a more proactive approach to menopause management.
This week's top women's health stories center on a landmark large-scale study linking longer reproductive lifespans to slower cognitive decline, a global scoping review revealing persistent gaps in menopause symptom awareness, and Black Maternal Health Week shining a spotlight on racial disparities in pregnancy outcomes. Meanwhile, the workplace implications of menopause continue to gain attention as new data confirms that over 80% of women experience symptoms yet most employers remain silent on the issue.
Create custom signals on any topic. AI curates and delivers 24/7.
Create SignalPowered by
